Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1634 of 6351
-
One shot or several? new trial tests shorter radiation for cancer spread
Disease control Recruiting nowStereotactic Ablative Radiotherapy (SABR) is a modern RT technique that delivers high doses of radiation to small tumor targets using highly conformal techniques, while trying to avoid healthy tissues and organs. However, SABR treatment requires increased planning, treatment time…
Sponsor: Robert Olson • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Can a tailored therapy ease stigma and boost mental health for young black and latino gay men?
Symptom relief CompletedThis open pilot involves testing the acceptability and feasibility of an intersectional, culturally responsive health intervention by piloting it among young Black and Latino/x gay, bisexual, and queer (GBQ+) men residing in Middle Tennessee. Qualitative exit interviews will be c…
Sponsor: Yale University • Aim: Symptom relief
Last updated Aug 30, 2026 00:00 UTC
-
New tests aim to outsmart superbug gonorrhea
Diagnosis CompletedThe goal of this study is to learn if a few investigational tests can correctly find the gene mutation (mutant allele gyrA 91F) that predicts ciprofloxacin resistance in clinical specimens that harbor Neisseria gonorrhoeae. The main question the study aims to answer: Can the inv…
Sponsor: Duke University • Aim: Diagnosis
Last updated Sep 05, 2026 00:00 UTC
-
New drug aims to tame tumor-triggered low blood sugar in rare cancer patients
Disease control Recruiting nowThe objectives of this study are to evaluate the glycemic efficacy, safety, and tolerability of ersodetug as add-on to standard of care (SOC) therapy for treatment of hypoglycemia in patients with Tumor Hyperinsulinism (Tumor HI).
Phase 3 • Sponsor: Rezolute • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Wall squats may lower blood pressure and slow artery damage, new study suggests
Disease control Recruiting nowBackground: Hypertension (HT) is the most common condition worldwide, predisposing to atherosclerotic disease. However, most HT patients have suboptimal BP control despite anti-HT medications. Isometric resistance exercise (IRE) (e.g. wall squat) may improve BP control, characte…
Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Could a Low-Dose immunotherapy boost chemo for hodgkin lymphoma?
Disease control Recruiting nowThe aim of the current trial is to evaluate the efficacy and safety of flat-dose nivolumab (40 mg) in combination with AVD in the management of patients with newly diagnosed advanced classic Hodgkin Lymphoma
Phase 2 • Sponsor: National Medical Research Radiological Centre of the Ministry of Health of Russia • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New drug duo targets Hard-to-Treat cancers
Disease control Recruiting nowThe primary objective of this study is to determine the recommended Phase 2 doses (RP2D(s)) and maximum tolerated dose (MTD) of PYX-201 in combination with pembrolizumab for participants with advanced solid tumors.
Phase 1/2 • Sponsor: Pyxis Oncology, Inc • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a vacuum dressing stop wound infections after breast cancer surgery?
Disease control Recruiting nowThere is little scientific data concerning the use of negative pressure therapy after immediate breast reconstruction. That strategy of treatment-reconstruction has expanded increasingly since the last years. The current literature reports only 3 studies on the use of preventiv…
Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Ultrasound could replace colonoscopies for Crohn's patients on new drug
Knowledge-focused OngoingCrohn's disease (CD) is a chronic inflammatory bowel disease (IBD) that can highly alter patients' quality of life and lead to bowel damage due to its transmural pattern. The current guidelines recommend to use treat-to-target strategies to achieve the combination of steroid-free…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:26 UTC
-
Exercise and sleep coaching show promise for children with autism
Symptom relief Recruiting nowAutism Spectrum Disorder (ASD) is a neurodevelopmental condition characterized by impairments in social interaction and communication. Children with ASD frequently experience co-occurring behavioral problems, among which sleep disturbances are highly prevalent, affecting approxim…
Sponsor: National Taiwan University Hospital • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
Could a simple nerve zap boost stroke rehab?
Symptom relief Recruiting nowTo evaluate feasibility and effectiveness of non-invasive VNS to enhance stroke recovery
Sponsor: The Methodist Hospital Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Magnetic heart scan could spot hidden chest pain causes
Diagnosis Recruiting nowThe aim of this prospective study is to identify Non-Obstructive Myocardial Ischemia of patients who have acute chest pain using Magnetocardiography.
Sponsor: Qilu Hospital of Shandong University • Aim: Diagnosis
Last updated Jun 27, 2026 14:02 UTC
-
Could HIV drugs help fight brain cancer? new trial launches
Disease control Recruiting nowThe purpose of this study is to determine whether newly diagnosed high-grade glioma(s) that cannot be removed surgically change as a result of the study treatment; and to identify and evaluate the potential side effects (good and bad) of the study treatment in patients with newly…
Phase 1 • Sponsor: University of Miami • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New heart procedure aims to zap AFib safely
Disease control OngoingThe purpose of this pragmatic study is to evaluate the safety, performance and effectiveness of the FARAPULSE catheter system (FARAWAVE catheter used in combination with the FARASTAR generator), to treat patients with atrial fibrillation during clinically-indicated ablation proce…
Phase 4 • Sponsor: Vivek Reddy • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Could a shot of your own blood beat botox for bladder control?
Disease control Recruiting nowOveractive bladder is a common condition that causes sudden urges to urinate, frequent urination, night-time urination, and sometimes leakage of urine. Many people with overactive bladder improve with lifestyle changes and medicines. However, some patients do not respond to these…
Sponsor: Benha University • Aim: Disease control
Last updated Jun 26, 2026 18:47 UTC
-
Diet or drugs? new study tests if fasting beats pills for fatty liver disease
Disease control By invitation onlyIn the Netherlands, there are many people with cardiometabolic diseases. More than half of these people also have fatty liver. This is a build-up of fat in the liver (steatosis) and can lead to long-term scarring (fibrosis) and even death of the liver. Losing weight can help redu…
Phase 4 • Sponsor: Carmen Dietvorst • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New cancer drug ABBV-324 enters first human trials
Disease control Recruiting nowHCC is a common cancer worldwide and a leading cause of cancer-related death. Lung cancer is the most frequently diagnosed cancer in the world, and the leading cause of cancer deaths. The purpose of this study is to assess adverse events and change in disease activity when ABBV-3…
Phase 1 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Gene-Guided dosing may tame dangerous fungal infections in blood cancer
Disease control Recruiting nowThis project aims to address invasive fungal infections in patients, by precision dosing of voriconazole based on CYP2C19 genotype testing with Bayesian dose-forecasting dosing software to develop patient-centric and maximally effective dosing regimens. This study investigates if…
Phase 2 • Sponsor: The University of Queensland • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Text messages tailored for american indian smokers could boost quit rates
Disease control Recruiting nowThe aim of this clinical trial is to test the efficacy of a culturally aligned digital smoking cessation resource for American Indian persons who smoke, via a remotely conducted randomized controlled trial.
Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New hope for tough pancreatic cancers: drug combo aims to shrink tumors before surgery
Disease control Recruiting nowThis is a multi-center, non-randomized, single-arm, open-label, phase Ib, dose escalation/dose expansion study of PTM-101 when combined with neoadjuvant chemotherapy for the treatment of treatment-naïve subjects with borderline resectable and locally advanced pancreatic ductal ad…
Phase 1 • Sponsor: PanTher Therapeutics • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC